Combining AHK-Cu with other evidence-based approaches often produces better results than any single intervention alone
Utilizing revolutionary Liposome Platform Technology (LPT), this formula ensures maximum bioavailability and rapid absorption of neuroprotective ingredients
Approved injection sites Three areas are standard for subcutaneous injection
The Bottom Line GHK-Cu sits in a strange spot in the peptide research world genuinely old research (Pickart's earliest work goes back to the 1970s), genuinely broad mechanistic reach (thousands of modulated genes), but still a compound where the human clinical trial base lags behind the mechanistic and cell-culture data
Recalls & Warnings February 13, 2014 Maker of Cholesterol and Workout Supplements Warned For Manufacturing Violations, Drug Claims and Unapproved Ingredient On January 31, 2014, the FDA issued a warning letter to Exclusive Supplements Inc
Follow these steps for safe application: Read the Label: Understand the recommended dosage and frequency